Michael J. Boyer
Chris O'Brien Lifehouse, 119-143 Missenden Road
Camperdown, NSW 2050, Australia
Camperdown, NSW 2050, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 130 publications
Amivantamab plus chemotherapy versus chemotherapy for first-line treatment of participants with EGFR exon 20 insertion-mutated advanced non-small cell lung cancer: PAPILLON Asia subgroup analysis.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 05, 2025
GDF15 biomarker performance in older patients with advanced non-small cell lung cancer.
Journal: Journal of geriatric oncology
Published: August 21, 2025
Economic evaluation of microvascular reconstruction of the jaw: A micro-costing analysis and identification of key cost-drivers.
Journal: Oral oncology
Published: August 03, 2025
Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 07, 2025
Assessing Second-Line Treatment Strategies and Outcomes in Epidermal Growth Factor Receptor (EGFR) Oncogene-Driven Stage IV Non-Small Cell Lung Cancer, Following a First-Line EGFR-TKI Therapy.
Journal: Cancer reports (Hoboken, N.J.)
Published: May 05, 2025
Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 18, 2024
Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 18, 2024
Impact of COVID-19 on lung cancer care in New South Wales, Australia: real-world data from the EnRICH Program.
Journal: Public health research & practice
Published: October 23, 2024
Impact of COVID-19 on lung cancer care in New South Wales, Australia: real-world data from the EnRICH Program.
Journal: Public health research & practice
Published: October 23, 2024
Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 29, 2024
Avelumab in Combination With Lorlatinib or Crizotinib in Patients With Previously Treated Advanced NSCLC: Phase 1b/2 Results From the JAVELIN Lung 101 Trial.
Journal: JTO clinical and research reports
Published: March 04, 2024
Last Updated: 09/26/2026